For the majority of vaccine reactions, the vaccine can still be administered in graded doses, according to John Kelso, MD, from the UC San Diego School of Medicine.
John Kelso
"All anaphylactic reactions to vaccines should be evaluated in an attempt to determine the culprit allergen," but do not simply avoid giving the vaccine, he said during his presentation on the vaccine research frontlines at the American College of Allergy, Asthma & Immunology 2020 Annual Scientific Meeting.
It might be tempting to simply label the patient as "allergic to the vaccine," but that "may leave the patient inadequately immunized," he said.
It's best to investigate the allergy with available resources and following allergy investigation procedures, said Kelso.
If the patient has had a previous reaction to a vaccine and has a reaction immediately after receiving the vaccine, do a skin-prick test or an invitro lgE test of the vaccine and its components, Kelso recommended.
All ingredients in every vaccine are listed in the vaccine excipient summary appendix of the Pinkbook, which is published by the Centers for Disease Control and Prevention.
And an online compilation of excipients in vaccines per 0.5mL dose, from the John Hopkins Bloomberg School of Public Health, breaks down vaccines by component, and lists the excipients and allergens, alphabetically, including the amount per dose.
If the test is negative and additional doses of the vaccine are required, administer the vaccine as indicated. If the test is positive and additional doses of the vaccine are needed, they can be administered in graded doses.
The same procedure is recommended if a patient has a clinical history of allergy to gelatin, latex, or yeast, which are common ingredients in vaccines.
"Although there are possibilities of false positives, a 1to 100 dilution for the intradermal test has been shown to be nonirritating," Kelso reported. What's more, "it's important to note that there are no reports of patients who have had intradermal skin tests and have gone on to have a reaction."
If the patient has a reaction to the vaccine, but not immediately, usually no allergy workup needed. In almost all such cases, the vaccine can be administered, on the recommended schedule, in graded doses at 15minute intervals, under observation, he said. If a physician is reluctant to give additional doses, a lab test can be done to measure the patient's lgG antibodies to see if they are protected.
"Most influenza vaccines are literally grown in egg," Kelso said, and "they contain a residual amount of egg protein, or ovalbumin."
However, this has been thoroughly studied with injectable influenza vaccine and intranasal influenza vaccine, live and attenuated, and reactions are rare.
In 27 studies of inactivated vaccine administered to more than 4100 children, including those who have had anaphylactic reactions to egg, there were no reactions, he reported. And published reports describe 1129 children with egg allergy who received live attenuated intranasal flu vaccine, with no immediate systemic reactions.
"It turns out there's just not enough egg protein present to cause a reaction even in the most severely egg allergic patient," Kelso explained. The maximum amount of ovalbumin is less than 1g per 0.5mL dose of influenza vaccine, and amounts measured in independent laboratories are usually much lower than the amounts claimed.
"It is not necessary to inquire about egg allergy before the administration of any influenza vaccine, including on screening forms," according to the Recommendations for Prevention and Control of Influenza in Children, 20202021, issued recently by the American Academy of Pediatrics.
This is one of three main changes in vaccine administration that clinicians "may wish to make" in practice, Kelso said.
The second is that clinicians should be aware that Tdap, a vaccine for tetanus diphtheria and pertussis, can be given regardless of when a previous Tdvaccination was given. Limb swelling, which occurs in 2% to 3% of people after four or five doses, is not a contraindication to the vaccine, he explained.
And the third is that pregnant women can receive injectable (inactivated) influenza vaccine and Tdap, but not live vaccines.
Lisa Saiman
Social media focuses predominantly on negative experiences, which "are easier to perceive than the positive benefits of vaccination: the absence of disease," Lisa Saiman, MD, from the Columbia University Irving Medical Center in New York City, pointed out during her presentation.
The result is a cognitive bias against vaccination, "a disbelief of vaccine efficacy, and a mistrust in pharmaceutical companies and, of course, government," she said.
"But there is a spectrum of vaccine hesitancy and refusal," Saiman said. And there are several resources that physicians can use to explain the importance of vaccines to those who fall into the "cautious acceptor" and "fence sitter" categories, which will help providers maximize the number of patients they vaccinate.
Saiman recommends that providers use talking points from the Countering Vaccine Hesitancy clinical report to guide discussions with parents who are worried about vaccines.
Regular courses of immunization need to be followed, she emphasized. "During the COVID-19 pandemic, measles vaccination rates have declined," and we "clearly are at increased risk of future outbreaks."
"We need to provide catch-up vaccinations expeditiously, and pediatricians must communicate the effectiveness and safety of all vaccines," she stressed.
Kelso and Saiman have disclosed no relevant financial relationships.
American College of Allergy, Asthma & Immunology (ACAAI) 2020 Annual Scientific Meeting: Presented November3, 2020.
Follow Medscape on Facebook, Twitter, Instagram, and YouTube
Follow this link:
Most Vaccines Can Be Give Safely, Even After Reactions - Medscape
- Inflation Reduction Act Projected to Impact Medicare Access to Immunology, Oncology, and Endocrinology Drugs in 2025 - geneonline.com - June 10th, 2025 [June 10th, 2025]
- Convocation 25: Adrien Lam, BSc Honors Immunology and Infection - University of Alberta - June 10th, 2025 [June 10th, 2025]
- Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off - R&D World - April 27th, 2025 [April 27th, 2025]
- Dr. Sabine Ehrt Named Chair of the Department of Microbiology and Immunology at Weill Cornell Medicine - WCM Newsroom - April 19th, 2025 [April 19th, 2025]
- RayThera launches with $110 million to advance immunology pipeline - The Pharma Letter - April 10th, 2025 [April 10th, 2025]
- Celebrate Vaccines: The legacy of the tetanus vaccine - British Society for Immunology - April 10th, 2025 [April 10th, 2025]
- Another immunology biotech emerges as Hillstar takes flight with $67M - Endpoints News - March 30th, 2025 [March 30th, 2025]
- Alumnus discovers passion for immunology, teaching at Mercer - Mercer University - March 15th, 2025 [March 15th, 2025]
- The future of immunology - Johnson & Johnson - March 5th, 2025 [March 5th, 2025]
- Immunotherapys Sweet Future: Wrapping up AACR IO 2025 With Glyco-immunology - American Association for Cancer Research (AACR) - March 5th, 2025 [March 5th, 2025]
- J&J receives three CHMP recommendations for immunology and oncology indications - PMLiVE - March 5th, 2025 [March 5th, 2025]
- Greater Austin Allergy, Asthma & Immunology now open in the Shops at the Galleria - Community Impact - March 5th, 2025 [March 5th, 2025]
- As dengue spreads, researchers discover a clue to fighting the virus - La Jolla Institute for Immunology - February 25th, 2025 [February 25th, 2025]
- Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress - Business... - February 25th, 2025 [February 25th, 2025]
- PhD candidate Jesse Lehman receives Kirschstein Award to study immunology - UMass Medical School - February 25th, 2025 [February 25th, 2025]
- Cross-priming in cancer immunology and immunotherapy - Nature.com - February 3rd, 2025 [February 3rd, 2025]
- Sanofi Happy To Spend To Hit Immunology Top Spot - News & Insights - February 3rd, 2025 [February 3rd, 2025]
- The Converging Therapeutic Landscape of Oncology and Immunology: Accelerating Innovation in Biotech - MedCity News - January 23rd, 2025 [January 23rd, 2025]
- VC Firm Foresite Capital Dishes on Biotech Innovation in China, Opportunities in Immunology - MedCity News - January 23rd, 2025 [January 23rd, 2025]
- Immunology - The Scientist - January 23rd, 2025 [January 23rd, 2025]
- Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System - MedCity News - January 15th, 2025 [January 15th, 2025]
- Scipher Medicine and Atropos Health Partner to Accelerate Precision Medicine and Expand the Immunology Multimodal Network - Business Wire - December 23rd, 2024 [December 23rd, 2024]
- AbbVie to expand immunology pipeline with $200m Nimble Therapeutics acquisition - PMLiVE - December 23rd, 2024 [December 23rd, 2024]
- Sir Gustav Nossal Professor of Immunology to honour giant of Australian science - Walter and Eliza Hall Institute of Medical Research - December 9th, 2024 [December 9th, 2024]
- Research Assistant in Immunology - Surrey, United Kingdom job with UNIVERSITY OF SURREY | 384335 - Times Higher Education - November 28th, 2024 [November 28th, 2024]
- Reflecting on Pioneering organoids and 3D cell cultures for animal and human health - British Society for Immunology | - November 28th, 2024 [November 28th, 2024]
- Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET - Business Wire - November 20th, 2024 [November 20th, 2024]
- TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development - Business Wire - November 20th, 2024 [November 20th, 2024]
- Discovering Solutions for Long COVID: A T-Cell Immunology Breakthrough - Infection Control Today - November 20th, 2024 [November 20th, 2024]
- Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET IPH6501 - The Bakersfield Californian - November 20th, 2024 [November 20th, 2024]
- Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of... - November 20th, 2024 [November 20th, 2024]
- What it's like in allergy and immunology: Shadowing Dr. Fraser - American Medical Association - November 12th, 2024 [November 12th, 2024]
- Dr. Naba Sharif Elected President of the New Jersey Allergy Asthma and Immunology Society - Newswire - November 12th, 2024 [November 12th, 2024]
- Department of Microbiology and Immunology Named a National Milestones Program - Stony Brook News - October 26th, 2024 [October 26th, 2024]
- Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting - businesswire.com - October 26th, 2024 [October 26th, 2024]
- Remembering immunology educator, researcher Tom McDonald, PhD - University of Nebraska Medical Center - October 13th, 2024 [October 13th, 2024]
- Systems immunology approaches to study T cells in health and disease - Nature.com - October 13th, 2024 [October 13th, 2024]
- Leading the charge to discover answers in immunology - The University of Arizona - October 2nd, 2024 [October 2nd, 2024]
- New mouse models offer valuable window into COVID-19 infection - La Jolla Institute for Immunology - October 2nd, 2024 [October 2nd, 2024]
- Wide-Moat AbbVie Poised for Growth, Driven by Innovation in Immunology Beyond Humira - Morningstar - October 2nd, 2024 [October 2nd, 2024]
- Lilly's immunology unit scores another FDA nod with eczema treatment Ebglyss - FiercePharma - September 23rd, 2024 [September 23rd, 2024]
- Huang Named Head Of Pathology And Immunology - Mirage News - September 15th, 2024 [September 15th, 2024]
- Huang named head of pathology & immunology - Washington University School of Medicine in St. Louis - September 15th, 2024 [September 15th, 2024]
- Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit - Yahoo Finance - September 15th, 2024 [September 15th, 2024]
- Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - StockTitan - September 15th, 2024 [September 15th, 2024]
- UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy - UCLA Newsroom - September 2nd, 2024 [September 2nd, 2024]
- Boosting vaccines for the elderly with 'hyperactivators' - Boston Children's Answers - Boston Children's Discoveries - June 27th, 2024 [June 27th, 2024]
- Immunologists Want You to Know These Dust Mite Allergy Facts - Yahoo Lifestyle UK - June 27th, 2024 [June 27th, 2024]
- How Ragon Institute's new building aids its mission Harvard Gazette - Harvard Gazette - June 27th, 2024 [June 27th, 2024]
- Insights into CRS and NPs: Visual and Bibliometric Analysis - Physician's Weekly - June 27th, 2024 [June 27th, 2024]
- Biogen joins immunology wave with $1.15 billion acquisition of HI-Bio - STAT - May 24th, 2024 [May 24th, 2024]
- Biogen Buys Desired Growth In Immunology With $1.15bn Hi-Bio Deal - Scrip - May 24th, 2024 [May 24th, 2024]
- Biogen Boosts Immunology Portfolio with $1.8 Billion Acquisition of HI-Bio - BioPharm International - May 24th, 2024 [May 24th, 2024]
- Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395 - Yahoo Finance - May 24th, 2024 [May 24th, 2024]
- Biogen to expand immunology and rare disease portfolio with $1.8bn HI-Bio acquisition - PMLiVE - May 24th, 2024 [May 24th, 2024]
- Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress - Business Wire - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B - MM+M Online - May 24th, 2024 [May 24th, 2024]
- COVID-19 Re-Vaccinations Elicit Neutralizing Antibodies Against Future Variants - Technology Networks - May 24th, 2024 [May 24th, 2024]
- HIV Vaccine Candidate Induces Broadly Neutralizing Antibodies in Humans - Technology Networks - May 24th, 2024 [May 24th, 2024]
- Pasteur Fiocruz Center on Immunology and Immunotherapy is inaugurated in Cear - Fiocruz - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal - Marketscreener.com - May 24th, 2024 [May 24th, 2024]
- Fellow Focus in Four: Marat Kribis, MD, Rheumatology, Allergy and Immunology - Yale School of Medicine - April 15th, 2024 [April 15th, 2024]
- Long COVID Can Now Be Detected in the Blood - Technology Networks - April 15th, 2024 [April 15th, 2024]
- Rimjhim Agarwal selected as Major Symposium speaker at the American Association of Immunologists ... - La Jolla Institute for Immunology - March 29th, 2024 [March 29th, 2024]
- Seeking new horizons: Where innovators find opportunities in a fast-changing immunology landscape - IQVIA - March 29th, 2024 [March 29th, 2024]
- Researchers identify new way to inhibit immune cells that drive allergic asthma - EurekAlert - March 29th, 2024 [March 29th, 2024]
- Innovation in Oncology and Cancer Immunology Research - Boehringer Ingelheim - March 29th, 2024 [March 29th, 2024]
- Measles outbreaks show the risk of under-vaccination | News | Harvard T.H. Chan School of Public Health - HSPH News - March 29th, 2024 [March 29th, 2024]
- Immunology-oncology ELISA Kits Market to Witness a Healthy Growth by 2030 - WhaTech - March 29th, 2024 [March 29th, 2024]
- Spring Allergy Season Is Getting Worse. Here's What to Know. - The New York Times - March 29th, 2024 [March 29th, 2024]
- Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments - STAT - March 29th, 2024 [March 29th, 2024]
- Researchers identify viable vaccine targets for hepatitis C infections - News-Medical.Net - March 29th, 2024 [March 29th, 2024]
- Three research projects awarded funding from the Immunology Institute Pilot Project program - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Deal Watch: AbbVie Adds To Immunology Pipeline Through Deal With OSE - Scrip - February 29th, 2024 [February 29th, 2024]
- AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology ... - PR Newswire - February 29th, 2024 [February 29th, 2024]
- Integrating single-cell multi-omics and prior biological knowledge for a functional characterization of the immune system - Nature.com - February 29th, 2024 [February 29th, 2024]
- Renowned immunologist and four-decade UAB researcher Max Cooper, M.D., will deliver this year's Marx Lecture - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Inactivation of TGF- signaling in CAR-T cells | Cellular & Molecular Immunology - Nature.com - February 29th, 2024 [February 29th, 2024]
- Babies use their immune system differently but efficiently | Cornell Chronicle - Cornell Chronicle - February 29th, 2024 [February 29th, 2024]
- Antibody reduces allergic reactions to multiple foods in NIH clinical trial - National Institutes of Health (NIH) (.gov) - February 29th, 2024 [February 29th, 2024]